Tech Transfer, Process Optimization & Troubleshooting

Seamless Tech Transfer, Sustained GMP Performance

Phosphorex ensures a smooth transition from development to GMP manufacturing through our well-established tech transfer playbook. Because we design the formulation and process, we offer critical knowledge that supports our clients and GMP manufacturers in optimizing GMP processes and providing expert troubleshooting to maintain performance, reproducibility, and regulatory confidence throughout the full product lifecycle.

Connect with Drug Delivery Experts

7-Point Tech Transfer Playbook

Successful tech transfer to a GMP manufacturing partner requires more than documentation; it demands structured knowledge transfer, risk mitigation, and technical continuity. The Phosphorex 7-Point Tech Transfer Playbook preserves formulation intent, protects critical quality attributes, and ensures seamless transition to GMP manufacturing with confidence, reproducibility, and regulatory alignment.

1

Define Transfer Scope & Objectives

We align on the development stage, target product profile, critical quality attributes, and GMP capabilities, establishing clear timelines and success criteria.

2

Process Knowledge Consolidation

Our team compiles development history, formulation rationale, CPP-CQA relationships, and product knowledge to preserve critical insights during transition.

3

Pilot-Scale Process Development

To significantly derisk tech transfer, we use equipment that is substantially equivalent to the future GMP environment. We develop processes and manufacture at the Phase I clinical scale.

4

Documentation Package Preparation

Phosphorex prepares a comprehensive GMP-ready documentation package, including process descriptions, risk assessments, CQA/CPP justifications, and Master Batch Records, ensuring clarity, reproducibility, and regulatory alignment.

5

Analytical Method Transfer & Qualification

Analytical methods are transferred, verified for robustness, assessed for comparability, and protocols finalized to ensure analytical consistency and regulatory defensibility.

6

GMP Batch Execution Support

Phosphorex can provide on-site or remote technical oversight during initial GMP runs, offering real-time troubleshooting, deviation assessment, and formulation integrity support.

7

Comparability & Change Impact Assessment

Following GMP production, we provide comparability support to confirm CQA consistency and collaborate on process changes with a clear understanding of the legacy process.

Ongoing Process Optimization & Troubleshooting

Ongoing Process Optimization & Troubleshooting

Process performance does not end at tech transfer. Because Phosphorex designed the formulation and process, our team often collaborates with GMP manufacturers to refine operating parameters, improve robustness, and optimize yield, cycle times, or downstream efficiency. If deviations occur, we can provide rapid root cause analysis, CQA impact assessment, and data-driven corrective strategies to restore consistency while preserving regulatory compliance and product integrity.

Core Drug Delivery Solutions

Phosphorex offers expertise in the three dominant particulate drug delivery platforms, tailoring them to address program-specific needs.

THE PHOSPHOREX DRUG DELIVERY ENGINE IN PRACTICE

Elevating Gene Editing LNP Quality

Problem

A biopharma company developing a novel co-encapsulated gene-editing LNP system was dissatisfied with the batch quality produced by its incumbent supplier. Variability in particle attributes and cargo integrity raised concerns about suitability for downstream development and clinical translation, prompting the search for a new delivery partner.

Solution

Phosphorex delivered a high-quality LNP batch with a 77 nm mean particle size, PDI of 0.039, and 97% encapsulation efficiency following a freeze/thaw cycle at –80 °C. mRNA cargo integrity closely matched the theoretical 1:1 ratio. The success led to a repeat project and a third engagement to explore new formulations.

Outcome

The highest-performing formulation was identified based on in vivo expression data. The program immediately advanced to scale-up, with Phosphorex producing an 85 mg batch of the selected formulation to support a subsequent rodent study, thereby accelerating development timelines and reducing formulation uncertainty.

The Phosphorex Drug Delivery Engine

The Phosphorex Drug Delivery Engine leverages our expertise and core drug-delivery technologies to optimize therapeutic performance, minimize systemic risks for patients, and ensure a scalable, clinical process design.
Formulation Optimization

Scalable, clinically relevant delivery systems

Discover Formulation Expertise
Analytical Expertise
Process Design & CMC

Tech Transfer, Process Optimization & Troubleshooting FAQs

Updates & Expertise

Leveraging Advanced Drug Delivery Systems to Improve Clinical Viability
Articles

Leveraging Advanced Drug Delivery Systems to Improve Clinical Viability

Development of Long-Acting Injectable Microspheres
Case Studies

Development of Long-Acting Injectable Microspheres

Post-Assembly Functionalization of Maleimide-Derivatized Lipid Nanoparticles with Peptide and Antibody Ligands via Thiol-Maleimide Conjugation Chemistry
Technical Bulletins

Post-Assembly Functionalization of Maleimide-Derivatized Lipid Nanoparticles with Peptide and Antibody Ligands via Thiol-Maleimide Conjugation Chemistry

Subject Matter Expert Video Series | Iro Vinales, Ph.D.
Videos

Subject Matter Expert Video Series | Iro Vinales, Ph.D.

Webinar on Demand | From Bench to Scale: Scaling Biodegradable mRNA Lipid Nanoparticle for Clinical Success
Webinars

Webinar on Demand | From Bench to Scale: Scaling Biodegradable mRNA Lipid Nanoparticle for Clinical Success

Ready to Engineer Particles for Precision Drug Delivery?

Ready to Engineer Particles for Precision Drug Delivery?

Partner with Phosphorex to transform your therapeutic vision into a precisely designed, clinically viable drug delivery solution.

Let’s Get Started